The new CAR-T therapy may pass ICER cost-effectiveness muster, but can the health care system afford more drugs like it?
Researchers used callers, posing as the uninsured, to call primary care offices. They got appointments if they could pay the fee. Things changed, however, if the callers tried to work out a deal by which they would pay in installments. Far fewer callers could get appointments in such cases.